Diclofenac Sodium Injection IP


  • Apenosa-D is a new propylene glycol-free and reduced volume formulation of Oiclofenac Sodium 75 mg/ ml.
  • Apenosa-D is found to be bioequivalent to a reference Oiclofenac Sodium 75 mg/ 3ml.
  • The mean plasma concentration and time to reach maximum plasma concentration for Apenosa-0 were 1.3 mcg/ml and 0.50 hours. Verses 0.93 mcg/ml and 1.08 hours for the Reference formulation.
  • Apenosa-0 attributes to faster absorption from the deltoid region than from the gluteal region.

  • Acute & chronic osteoarthritis & rheumatoid arthritis
  • Low back pain, Ankylosing spondylitis
  • Acute musculo-skeletal disorder
  • Apenosa-D Post-traumatic & post-operative pain, Inflammation & swelling
  • Pain relief in dysmenorrhea
  • Abdominal cramps Renal-€ lie-& Biliar_y, Colic
  • Diclofenac 75 mg/ ml.
  • Acute attack of Gout